source
- Dr. Hunter outlines anemia treatment options for myelofibrosis patientsDr. Anthony M. Hunter, a hematology specialist, discussed how clinicians approach anemia in patients with myelofibrosis. He highlighted luspatercept as one therapeutic option, noting its mechanism…
- FDA approves oral decitabine/cedazuridine plus venetoclax for older AML patients unable to tolerate intensive chemoThe FDA has approved the oral combination of decitabine/cedazuridine (Inqovi) with venetoclax (Venclexta) for adults with newly diagnosed acute myeloid leukemia who are at least 75 years old or hav…